Try our Advanced Search for more refined results
January 10, 2023
Acorda Therapeutics, Inc. v. Alkermes plc
Case Number:
1:23-cv-00223
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 07, 2023
Judge Backs Acorda's $16.6M Award In MS Drug Row
A New York federal judge has confirmed a nearly $16.6 million arbitral award issued to Acorda Therapeutics Inc. in its dispute with Alkermes PLC over a multiple sclerosis drug, but refused to increase the award by $65.6 million to refund the company for royalties paid after the drug's patent expired.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login